WITHAFERIN A: A NOVEL THERAPEUTIC APPROACH FOR MALIGANT BRAIN TUMORS

Patrick T. Grogan(Moffitt Cancer Center)

KU ScholarWorks (The University of Kansas)

August 31, 2014

Cited by 0

Related Papers

Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts

|Neuro-Oncology|2008|387

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel

|Molecular Cancer Therapeutics|2007|203

Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model

|Journal of Neuro-Oncology|2008|97

Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines

|Molecular Cancer Therapeutics|2009|94